Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03440905 · ClinicalTrials.gov registry record
Proxy-Reported Symptoms and Quality of Life Survey in Zellweger Spectrum Disorders
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 92
- Enrollment target
NCT03440905 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 92 participants.
The verdict
NCT03440905 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the symptoms of Zellweger Spectrum Disorder (ZSD) and related peroxisome disorders, and to assess the quality of life of family caregivers (parents, stepparents, legal guardians) of patients diagnosed with ZSD or a related peroxisome disorder. All family caregivers of patients enrolled in the Rare Diseases Clinical Research Network (RDCRN) Contact Registry who are diagnosed with ZSD or a related peroxisome disorder will be invited via email to participate in this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2018-01-29 |
| Est. Completion | 2018-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03440905
The ClinicalTrials.gov registry entry for NCT03440905 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03440905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03440905 about?
NCT03440905 is a clinical study titled "Proxy-Reported Symptoms and Quality of Life Survey in Zellweger Spectrum Disorders". The purpose of this study is to characterize the symptoms of Zellweger Spectrum Disorder (ZSD) and related peroxisome disorders, and to assess the quality of life of family caregivers (parents, stepparents, legal guardians) of patients diagnosed with ZSD or a related peroxisome disorder. All family ...
What is the current status of trial NCT03440905?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2018-01-29. Estimated completion is 2018-11-30.
Who is sponsoring clinical trial NCT03440905?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.